These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 20080894

  • 1. Movement correction method for human brain PET images: application to quantitative analysis of dynamic 18F-FDDNP scans.
    Wardak M, Wong KP, Shao W, Dahlbom M, Kepe V, Satyamurthy N, Small GW, Barrio JR, Huang SC.
    J Nucl Med; 2010 Feb; 51(2):210-8. PubMed ID: 20080894
    [Abstract] [Full Text] [Related]

  • 2. Automated movement correction for dynamic PET/CT images: evaluation with phantom and patient data.
    Ye H, Wong KP, Wardak M, Dahlbom M, Kepe V, Barrio JR, Nelson LD, Small GW, Huang SC.
    PLoS One; 2014 Feb; 9(8):e103745. PubMed ID: 25111700
    [Abstract] [Full Text] [Related]

  • 3. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of Logan and relative-equilibrium graphical methods for parametric imaging of dynamic [18F]FDDNP PET determinations.
    Wong KP, Kepe V, Dahlbom M, Satyamurthy N, Small GW, Barrio JR, Huang SC.
    Neuroimage; 2012 Mar 15; 60(1):241-51. PubMed ID: 22197787
    [Abstract] [Full Text] [Related]

  • 5. FDDNP binding using MR derived cortical surface maps.
    Protas HD, Huang SC, Kepe V, Hayashi K, Klunder A, Braskie MN, Ercoli L, Bookheimer S, Thompson PM, Small GW, Barrio JR.
    Neuroimage; 2010 Jan 01; 49(1):240-8. PubMed ID: 19703569
    [Abstract] [Full Text] [Related]

  • 6. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
    Barrio JR, Kepe V, Satyamurthy N, Huang SC, Small G.
    J Nutr Health Aging; 2008 Jan 01; 12(1):61S-5S. PubMed ID: 18165848
    [Abstract] [Full Text] [Related]

  • 7. Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease.
    Kuntner C, Kesner AL, Bauer M, Kremslehner R, Wanek T, Mandler M, Karch R, Stanek J, Wolf T, Müller M, Langer O.
    Mol Imaging Biol; 2009 Jan 01; 11(4):236-40. PubMed ID: 19214638
    [Abstract] [Full Text] [Related]

  • 8. Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.
    Wong KP, Wardak M, Shao W, Dahlbom M, Kepe V, Liu J, Satyamurthy N, Small GW, Barrio JR, Huang SC.
    Eur J Nucl Med Mol Imaging; 2010 Mar 01; 37(3):575-88. PubMed ID: 19882153
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.
    Tolboom N, Yaqub M, van der Flier WM, Boellaard R, Luurtsema G, Windhorst AD, Barkhof F, Scheltens P, Lammertsma AA, van Berckel BN.
    J Nucl Med; 2009 Feb 01; 50(2):191-7. PubMed ID: 19164243
    [Abstract] [Full Text] [Related]

  • 11. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW, Kepe V, Ercoli LM, Siddarth P, Bookheimer SY, Miller KJ, Lavretsky H, Burggren AC, Cole GM, Vinters HV, Thompson PM, Huang SC, Satyamurthy N, Phelps ME, Barrio JR.
    N Engl J Med; 2006 Dec 21; 355(25):2652-63. PubMed ID: 17182990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles.
    Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S, Serdons K, Bormans G, Tsai K, Walji A, Hostetler ED, Evelhoch JL, Van Laere K, Forman M, Stoch A, Sur C, Struyk A.
    J Nucl Med; 2019 Jan 21; 60(1):107-114. PubMed ID: 29880509
    [Abstract] [Full Text] [Related]

  • 14. Motion artifact reduction on parametric PET images of neuroreceptor binding.
    Herzog H, Tellmann L, Fulton R, Stangier I, Rota Kops E, Bente K, Boy C, Hurlemann R, Pietrzyk U.
    J Nucl Med; 2005 Jun 21; 46(6):1059-65. PubMed ID: 15937320
    [Abstract] [Full Text] [Related]

  • 15. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.
    Braskie MN, Klunder AD, Hayashi KM, Protas H, Kepe V, Miller KJ, Huang SC, Barrio JR, Ercoli LM, Siddarth P, Satyamurthy N, Liu J, Toga AW, Bookheimer SY, Small GW, Thompson PM.
    Neurobiol Aging; 2010 Oct 21; 31(10):1669-78. PubMed ID: 19004525
    [Abstract] [Full Text] [Related]

  • 16. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
    Wong DF, Rosenberg PB, Zhou Y, Kumar A, Raymont V, Ravert HT, Dannals RF, Nandi A, Brasić JR, Ye W, Hilton J, Lyketsos C, Kung HF, Joshi AD, Skovronsky DM, Pontecorvo MJ.
    J Nucl Med; 2010 Jun 21; 51(6):913-20. PubMed ID: 20501908
    [Abstract] [Full Text] [Related]

  • 17. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M, Wall A, Chiotis K, Saint-Aubert L, Wilking H, Sprycha M, Borg B, Thibblin A, Eriksson J, Sörensen J, Antoni G, Nordberg A, Lubberink M.
    J Nucl Med; 2016 Apr 21; 57(4):574-81. PubMed ID: 26795290
    [Abstract] [Full Text] [Related]

  • 18. Differential FDDNP PET patterns in nondemented middle-aged and older adults.
    Ercoli LM, Siddarth P, Kepe V, Miller KJ, Huang SC, Cole GM, Lavretsky H, Bookheimer SY, Kim J, Phelps ME, Barrio JR, Small GW.
    Am J Geriatr Psychiatry; 2009 May 21; 17(5):397-406. PubMed ID: 19390297
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.
    Ossenkoppele R, Tolboom N, Foster-Dingley JC, Adriaanse SF, Boellaard R, Yaqub M, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.
    Eur J Nucl Med Mol Imaging; 2012 Jun 21; 39(6):990-1000. PubMed ID: 22441582
    [Abstract] [Full Text] [Related]

  • 20. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand 18F-MK-6240 in Humans from Alzheimer Disease Dementia to Young Controls.
    Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT.
    J Nucl Med; 2019 Jan 21; 60(1):93-99. PubMed ID: 29777006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.